Germany’s BioNTech said Thursday it still intends to provide Taiwan with coronavirus vaccine doses after the island’s health chief warned “political pressure” had scuppered a deal with the company.
Taiwanese health minister Chen Shih-chung said Wednesday that negotiations with the German firm to acquire five million Pfizer/BioNTech shots fell through in December “because someone doesn’t want Taiwan to be too happy”.
His comments raised concerns China might be trying to hinder Taiwan’s inoculation drive.
Authoritarian Beijing regards democratic and self-ruled Taiwan as its own territory and tries to keep the island diplomatically isolated—including keeping it locked out of the World Health Organization.
In a statement on Thursday, BioNTech said discussions to supply Taiwan with doses were still ongoing.
“BioNTech is committed to help bringing an end to the pandemic for people across the world and we intend to supply Taiwan with our vaccine as part of this global commitment,” it said.
The brief statement did not address Chen’s comments or explain why the December deal did not materialise.
BioNTech has struck a deal with the Shanghai-based Fosun Pharmaceutical Group to bring the vaccine to China, including Taiwan.
Beijing has a long history of pressuring both Chinese and international companies when it wants to punish Taiwan.
There has been no comment on Chen’s remarks in China during the annual lunar new year break. Foson has also not responded to requests for comment.
Taiwan has survived the pandemic largely unscathed—with fewer than 940 confirmed cases and nine deaths so far—by closing its borders early, imposing strict quarantine measures and rolling out effective tracing.
But it has struggled to locate adequate vaccine supplies and only recently announced a supply of five million doses by American pharmaceutical giant Moderna and 200,000 doses of Oxford-AstraZeneca vaccine via COVAX.
Follow the latest news on the coronavirus (COVID-19) outbreak
© 2021 AFP
BioNTech says ‘committed’ to supplying Taiwan with vaccine (2021, February 18)
retrieved 18 February 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- South African regulator rejects Russia’s COVID-19 vaccine - October 20, 2021
- Second wave of pandemic not receded yet, third wave feared post-Diwali: Maha health minister - October 20, 2021
- WHO chief discusses Covaxin, resumption of AstraZeneca vaccine supplies to COVAX facility with Health Minister Mandaviya - October 20, 2021
- Trivitron Healthcare in collaboration with Diagon- Vanguard Diagnostics launches Diagon’s Coagulation range in India - October 20, 2021
- Breast cancer early detection, screening, and management – what we need to know - October 20, 2021
- WHO’s technical advisory group to meet on Oct 26 to consider Covaxin - October 19, 2021
- 163 oxygen plants set up in MP after shortage during 2nd COVID-19 wave: CM Shivraj Singh Chouhan - October 19, 2021
- India’s R-value below 1 since September, researchers say - October 19, 2021
- Mumbai: Double vaccine jab not mandatory to enter theatres, colleges to reopen with 50% attendance - October 19, 2021
- Daily exercise routine, balanced diet, active lifestyle & quality sleep key to success in personal & professional lives: Experts - October 19, 2021